TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 1 | -5 | -1 | 3 | 4 | 6 | 3 | 2 |
| S | %wins | 100 | 100 | 0 | 0 | 0 | 0 | 33 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/21/26 19:41 | 8/19/26 | AEON | Aeon Biopharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Lynch Timothy P | OR | T | P | 243 | 0.2117 | 0 | 1,150 | 21 | 6,500 | D | |||||||||||||||
11/18/09 19:54 | 11/17/09 | NABI | Nabi Biopharmaceuticals | DE | Health | BioPrd | Biological Products, (No Diag | Lynch Timothy P | MD | D | S | -20 | 5.20 | 2 | -4 | -100 | 0 | D | 44 | 59 | 88 | 63 | 41 | 61 | 52 | 52 | -5 | -1 | 3 | 4 | 6 | 3 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |